Derived tyrosine hydroxylase gene expression system
US6432701B1 · kind B1 · utility
0Cited by
0References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 1998 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Oct 14, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/021
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention discloses a new system for gene expression. The system is based in particular on the use of derived sequences of the first intron of the tyrosine hydroxylase gene having transcription enhancing properties. The system is particularly useful in the production of proteins in vitro, ex vivo or in vivo, particularly in gene therapy applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.